Innovative Approaches for Overcoming Challenges in the Development of Coagulation-based Therapeutics

The management of common and orphan diseases is challenging due to aberrant bleeding or coagulation. To achieve better disease control, modern therapeutics aim to improve precision and safety over traditional agents by leveraging highly selective and/or targeted modalities. While clotting and bleeding assays have been in use for many decades for analyzing blood products, standard approaches are not well suited to support development of modern therapeutics. Download this article to learn how innovative therapeutics require the development of a fit-for-purpose coagulation assay.